← brief for 2026-08-19 · Slowing decline

SGLT2 inhibitors in kidney transplant recipients: metabolic changes, potassium-related safety and implications for albuminuria assessment

Paper B Peer reviewed Small trial

Key takeaways

SGLT2 inhibitors in kidney transplant recipients: a study of 100 patients over 3 years. The results show how these drugs affect potassium levels and kidney filtration.

Who did this work

Lino Henkel (University Hospital Münster) · Lisa Ingmanns (University Hospital Münster) · Florian Westphal (University Hospital Zurich) · Amélie F. Menke (University Hospital Münster) · Hermann Pavenstädt (University Hospital Münster) · Ulrich Jehn (Nephrologisches Zentrum Emsland) · Göran R. Boeckel (University Hospital Münster) · Stefan Reuter (University Hospital Münster)

Source

Paper · OpenAlex, CKD works · 2026-08-18
https://doi.org/10.3389/frtra.2026.1927374